Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Motus GI Holdings Inc. (MOTS:NASDAQ), powered by AI.
Motus GI Holdings Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Motus GI Holdings Inc. on Alpha Lenz.
View Motus GI Holdings Inc.'s valuation metrics on Alpha Lenz.
“Motus GI Holdings Inc.'s ROE is -454.3%. Explore profitability and growth together.”
Ask for details →Motus GI Holdings Inc. is a medical technology company focused on enhancing clinical outcomes in gastrointestinal diagnostics. The company's primary innovation is the Pure-Vu System, a device designed to facilitate the cleaning of the gastrointestinal tract during colonoscopy and upper endoscopy procedures. The Pure-Vu System integrates seamlessly with standard gastroscopes and colonoscopes, allowing endoscopists to efficiently cleanse inadequately prepared colons intra-procedurally, thereby improving visualization and the overall quality of the exam. By supporting better cleansing, the system aims to minimize delays and incomplete procedures, which are significant challenges in inpatient colonoscopy. Motus GI Holdings Inc. addresses unmet needs in endoscopy by improving procedural efficiency, reducing hospital costs, and supporting better patient outcomes. Headquartered in Fort Lauderdale, Florida, and with subsidiaries in the U.S. and Israel, the company serves hospitals and healthcare providers seeking effective and cost-efficient solutions for gastrointestinal diagnostics.
“Motus GI Holdings Inc.'s ROE is -454.3%. Explore profitability and growth together.”
Ask for details →Motus GI Holdings Inc. (ticker: MOTS) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 15 employees. Market cap is $81.
The current price is $0 with a P/E ratio of -x and P/B of -x.
ROE is -454.34% and operating margin is -3732.60%. Annual revenue is $319,000.